AI-generated summary
The authors report a double-blind, randomized trial of 120 ischemic stroke patients treated within 24 hours of onset, comparing an infrared laser system with sham control. They found more patients in the active group had better 90-day outcomes on the primary NIHSS-based measure (70% versus 51%) and on the modified Rankin Scale. The authors describe these results as preliminary and call for a larger confirmatory trial.
- Participants
- 120
- Who or what was studied
- Ischemic stroke patients treated within 24 hours of onset with baseline NIHSS scores of 7 to 22, excluding those given tissue plasminogen activator.
- Limits stated in the abstract
- The authors describe the findings as preliminary and state that a larger confirmatory trial is warranted, with results shown across several stratified analyses.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ahajournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Stroke, Laser, Primary outcome, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.